Cardinal Health, Inc. $CAH Shares Acquired by Raymond James Financial Inc.

Raymond James Financial Inc. lifted its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 48.8% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 567,782 shares of the company’s stock after buying an additional 186,325 shares during the quarter. Raymond James Financial Inc. owned approximately 0.24% of Cardinal Health worth $78,223,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also made changes to their positions in the company. JPMorgan Chase & Co. increased its holdings in Cardinal Health by 40.0% in the first quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company’s stock valued at $575,327,000 after buying an additional 1,193,983 shares during the last quarter. Northern Trust Corp increased its holdings in Cardinal Health by 16.2% in the fourth quarter. Northern Trust Corp now owns 3,037,849 shares of the company’s stock valued at $359,286,000 after buying an additional 422,755 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in Cardinal Health by 4.3% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,321,797 shares of the company’s stock valued at $274,599,000 after buying an additional 94,768 shares during the last quarter. Price T Rowe Associates Inc. MD increased its holdings in Cardinal Health by 3.6% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 1,601,322 shares of the company’s stock valued at $189,390,000 after buying an additional 55,781 shares during the last quarter. Finally, Castlekeep Investment Advisors LLC bought a new stake in Cardinal Health in the fourth quarter valued at about $141,963,000. Institutional investors and hedge funds own 87.17% of the company’s stock.

Insider Buying and Selling

In other news, insider Ola M. Snow sold 28,151 shares of the stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.94, for a total value of $4,192,809.94. Following the completion of the transaction, the insider owned 15,431 shares of the company’s stock, valued at approximately $2,298,293.14. This represents a 64.59% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, insider Michelle D. Greene sold 13,500 shares of the stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total value of $2,009,070.00. Following the completion of the transaction, the insider directly owned 14,976 shares of the company’s stock, valued at approximately $2,228,728.32. The trade was a 47.41% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 235,775 shares of company stock valued at $35,102,939. Company insiders own 0.09% of the company’s stock.

Cardinal Health Stock Down 0.5%

Cardinal Health stock opened at $149.0390 on Wednesday. The firm has a 50-day moving average price of $159.47 and a two-hundred day moving average price of $144.94. The firm has a market capitalization of $35.59 billion, a price-to-earnings ratio of 23.11, a PEG ratio of 1.26 and a beta of 0.67. Cardinal Health, Inc. has a 52-week low of $106.54 and a 52-week high of $168.44.

Cardinal Health (NYSE:CAH) last posted its earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.03 by $0.05. The firm had revenue of $60.16 billion during the quarter, compared to analyst estimates of $60.91 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. Cardinal Health’s revenue was up .5% on a year-over-year basis. During the same period in the previous year, the business posted $1.84 EPS. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. Research analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be paid a $0.5107 dividend. The ex-dividend date of this dividend is Wednesday, October 1st. This represents a $2.04 annualized dividend and a dividend yield of 1.4%. Cardinal Health’s dividend payout ratio is presently 31.63%.

Analysts Set New Price Targets

CAH has been the subject of several research analyst reports. UBS Group reissued a “buy” rating on shares of Cardinal Health in a report on Tuesday, August 12th. Jefferies Financial Group set a $150.00 target price on shares of Cardinal Health in a report on Tuesday, August 12th. Bank of America increased their target price on shares of Cardinal Health from $165.00 to $170.00 and gave the stock a “buy” rating in a report on Tuesday, June 10th. Citigroup reissued a “neutral” rating and set a $170.00 target price (up from $157.00) on shares of Cardinal Health in a report on Friday, June 13th. Finally, Morgan Stanley reissued an “overweight” rating on shares of Cardinal Health in a report on Tuesday, August 12th. Twelve research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $163.20.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.